To screen ETFs by asset class, performance, yield and more, check out the
FDA approves new use for Eylea. More upside to Regeneron $
Add a reply...
Latest StockTalks »
people get REGN breaking news and analysis by email alert.
Get email alerts on REGN »
Regeneron Pharmaceuticals, Inc.
Get latest price
From other sites
The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases
at Zacks.com (Tue, 9:30AM)
Regeneron (REGN) Beats on Q1 Earnings, Updates 2015 View - Tale of the Tape
at Zacks.com (May 7, 2015)
REGENERON PHARMACEUTICALS INC FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits
at 4-traders.com (Mar 23, 2015)
Cramer's first CEO guest, 10 years later
at CNBC.com (Mar 12, 2015)
Regeneron Guidance Strong
at Investor's Business Daily (Feb 10, 2015)
Xignite quote data
© 2015 Seeking Alpha